Unexpected guests in the tumor microenvironment:microbiome in cancer
作者机构：Thoracic and Gastrointestinal Malignancies BranchNational Cancer InstituteNational Institutes of Health4 Memorial DriveBethesdaMD 20892USA Department of Cancer BiologyPerelman School of MedicineUniversity of Pennsylvania421 Curie Blvd.PhiladelphiaPA 19104USA
出 版 物：《Protein & Cell》 (蛋白质与细胞（英文版）)
年 卷 期：2021年第12卷第5期
页 面：426-435页
核心收录：
学科分类：0710[理学-生物学] 0831[工学-生物医学工程（可授工学、理学、医学学位）] 1007[医学-药学(可授医学、理学学位)] 1002[医学-临床医学] 0703[理学-化学] 100214[医学-肿瘤学] 0836[工学-生物工程] 10[医学]
基 金：Figures are created with BioRender.C.J.is supported in part by a R00 Award from NIH/NCI(CA226400) an Emerson Collective Cancer Research Fund,and a Lung Cancer Research Foundation(LCRF)Pilot Grant.C.Z.is supported in part by the Intramural Research Program of the NIH,National Cancer Institute,Center for Cancer Research,SITC-AstraZeneca Immunotherapy in Lung Cancer(Early Stage NSCLC)Clinical Fellowship Award
主 题：microbiome tumor lung cancer immune system tumor-associated microbiota cancer immunotherapy
摘 要：Although intestinal microbiome have been established as an important biomarker and regulator of cancer development and therapeutic response, less is known about the role of microbiome at other body sites in cancer. Emerging evidence has revealed that the local microbiota make up an important part of the tumor microenvironment across many types of cancer, especially in cancers arising from mucosal sites, including the lung, skin and gastrointestinal tract. The populations of bacteria that reside specifically within tumors have been found to be tumor-type specific, and mechanistic studies have demonstrated that tumor-associated microbiota may directly regulate cancer initiation, progression and responses to chemo- or immuno-therapies. This review aims to provide a comprehensive review of the important literature on the microbiota in the cancerous tissue, and their function and mechanism of action in cancer development and treatment.
维普期刊数据库